# South Korea Heart Valves Market

> South Korea Heart Valves Market Research Report: Size, Share, Trend Analysis By Types (Mechanical Valves, Bioprosthetic Valves, Transcatheter Valves), By Applications (Aortic Valve Repair, Mitral Valve Repair, Tricuspid Valve Repair), By End Use (Hospital, Ambulatory Surgical Centers, Cardiac Clinics) and By Material (Biological Tissue, Synthetic Polymer, Metallic Alloys) - Growth Outlook & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 12.2%
- **2024:** $ 227.2 Million
- **2025:** $ 254.92 Million
- **2035:** $ 806.17 Million
- **Key Players:** Edwards Lifesciences (US), Medtronic (US), Boston Scientific (US), Abbott Laboratories (US), LivaNova (GB), JenaValve Technology (DE), Sorin Group (IT), CryoLife (US)

**Report ID:** MRFR/MED/50349-HCR · **Pages:** 200 · **Author:** Rahul Gotadki · **Last Updated:** February 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/south-korea-heart-valves-market-52107

---

## Market Summary

## **South Korea Heart Valves Market Overview**

As per MRFR analysis, the South Korea Heart Valves Market Size was estimated at 185.13 (USD Million) in 2023. The South Korea Heart Valves Market Industry is expected to grow from 192.8(USD Million) in 2024 to 384.5 (USD Million) by 2035. The South Korea Heart Valves Market CAGR (growth rate) is expected to be around 6.476% during the forecast period (2025 - 2035).

**Key South Korea Heart Valves Market Trends Highlighted**

The South Korea Heart Valves Market is witnessing several significant trends driven by various factors. One of the key market drivers is the growing prevalence of cardiovascular diseases among the aging population. With a rapidly increasing elderly demographic, the demand for heart valve procedures is on the rise, leading to more advanced treatment options. 

Additionally, advancements in medical technology have enabled the development of minimally invasive heart valve replacement procedures, which are becoming increasingly popular in South Korea. This shift not only improves patient recovery times but also enhances overall clinical outcomes. Opportunities to be explored in this market include the potential for expansion in telemedicine and remote patient monitoring, particularly following the COVID-19 pandemic.These digital solutions could be instrumental in the provision of follow-up care for heart valve patients as healthcare systems strive to enhance patient engagement and comply with safety protocols. 

Additionally, local manufacturers are investing in research and development to develop innovative heart valve products that are specifically designed to meet the requirements of South Korean patients. This presents a promising opportunity for market expansion. In recent years, there has been a growing emphasis on bioprosthetic heart valves due to their decreased reliance on anticoagulation and their long-term efficacy. The development of new products is also being facilitated by South Korea's emphasis on the promotion of partnerships between research institutions and medical device companies and the improvement of healthcare infrastructure.

In general, the South Korea Heart Valves Market is continuing to be influenced by a supportive regulatory environment, a growing patient population, and advanced technology, which underscores the importance of stakeholders considering dynamic trends.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

**South Korea Heart Valves Market Drivers**

**Rising Prevalence of Cardiovascular Diseases**

The South Korea Heart Valves Market is experiencing significant growth driven by the increasing prevalence of cardiovascular diseases. According to the Ministry of Health and Welfare in South Korea, cardiovascular disease is the leading cause of death, accounting for approximately 30% of all deaths in the country. This alarming statistic underlines a growing patient population that is likely to require heart valve interventions over the coming years.Major establishments such as the Korean Society of Interventional Cardiology are actively researching and developing innovative treatment options, which further enhance market demand. 

Additionally, the Korean Institute of Cardiovascular Disease documented an increase in heart-related ailments by over 15% in recent years, indicating an urgent need for effective heart valve solutions. This situation presents a robust opportunity for the South Korea Heart Valves Market Industry as healthcare providers seek advanced technologies to manage and treat rising cardiovascular issues.

**Technological Advancements in Heart Valve Devices**

The South Korea Heart Valves Market is propelled by rapid technological advancements in heart valve devices. Recent innovations, such as transcatheter aortic valve replacement (TAVR) systems and minimally invasive surgical techniques, have gained traction in South Korea. According to the South Korean Ministry of Health and Welfare, TAVR cases have surged by about 25% annually, showcasing the growing acceptance of these advanced procedures.

 Renowned organizations, including Seoul National University Hospital, are pioneering Research and Development (R&D) efforts focused on enhancing the safety and efficacy of these devices.These advancements not only broaden the treatment options available to patients but also improve recovery times, creating a positive outlook for the South Korea Heart Valves Market Industry.

**Aging Population in South Korea**

The South Korea Heart Valves Market is significantly influenced by the aging population, which is leading to a higher incidence of heart valve-related disorders. The Korea Statistical Information Service predicts that by 2025, nearly 20% of South Korea's population will be 65 years or older. This demographic shift results in a growing incidence of age-related cardiovascular diseases, as older individuals are more susceptible to complications that necessitate heart valve repairs or replacements.

Institutions like the Korean National Health Insurance Service are observing an upward trend in the number of heart surgeries being performed, which is creating a substantial demand for heart valve solutions. Such demographic changes will provide continued growth opportunities for the South Korea Heart Valves Market Industry.

**South Korea Heart Valves Market Segment Insights**

**Heart Valves Market Type Insights**

The South Korea Heart Valves Market has been experiencing notable growth, driven by the need for advanced cardiac care and improved patient outcomes. The market can be categorized primarily into Mechanical Valves, Bioprosthetic Valves, and Transcatheter Valves, each holding its unique significance in the overall landscape. Mechanical Valves are known for their durability and longevity, making them a favored choice for patients who require long-term intervention. Their ability to withstand high pressure and continuous use is a critical factor in their prevalence, particularly among younger patients who may require years of functionality. 

Bioprosthetic Valves, on the other hand, offer the advantage of reduced thrombogenicity, making them an appealing option for older patients or those who may face an increased risk of blood clots. Their compatibility with the human body and the lower need for anticoagulation therapy underline their growing adoption in South Korea. As the population ages and the prevalence of heart disease rises, the demand for these valves will likely continue to escalate, reflecting changing patient profiles and medical technologies. Transcatheter Valves are gaining traction as a minimally invasive alternative, revolutionizing treatment for patients who are at higher surgical risks. 

By allowing for valve replacement through a catheter, these devices not only improve recovery times but also expand treatment options for those previously considered inoperable. The rise of minimally invasive procedures aligns well with the increasing focus on patient-centered care viewed in the South Korean healthcare industry, illustrating the shift toward innovative procedural methodologies. The innovations and advancements within each type segment not only enhance surgical outcomes but also contribute to the overall South Korea Heart Valves Market revenue. 

As technological developments continue, each valve type is expected to evolve, addressing patient needs and improving health outcomes across diverse demographics. Overall, the dynamics of the market segmentation within the South Korea Heart Valves Market is indicative of a broader trend towards personalized and efficient medical solutions in cardiovascular treatment.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

**Heart Valves Market Application Insights**

The Application segment of the South Korea Heart Valves Market is characterized by its focus on essential procedures such as Aortic Valve Repair, Mitral Valve Repair, and Tricuspid Valve Repair, addressing significant cardiovascular issues faced in the region. Aortic Valve Repair has gained prominence due to the increasing prevalence of aortic stenosis among the aging population, often leading to the need for interventions to enhance patient outcomes. Mitral Valve Repair, another key area, plays a crucial role as mitral valve regurgitation affects a significant portion of the population, necessitating efficient repair techniques to improve heart function.

Tricuspid Valve Repair is also vital, as it addresses both primary and secondary valvular diseases that can lead to right heart failure, emphasizing the importance of early detection and surgical intervention. The growing focus on minimally invasive procedures and advancements in surgical techniques are driving innovations across these applications, while the increasing health awareness and clinical research efforts within South Korea further support the market's expansion in this segment. Overall, these applications are fundamental in shaping treatment pathways and improving the quality of life for patients with heart valve disorders in the country.

**Heart Valves Market End Use Insights**

The South Korea Heart Valves Market exhibits significant segmentation in the End Use category, primarily encompassing Hospitals, Ambulatory Surgical Centers, and Cardiac Clinics. Hospitals are critical players in this segment due to their comprehensive facilities and specialized staff, which cater to complex heart valve procedures and surgeries. With the increasing prevalence of cardiovascular diseases, these medical institutions provide essential care, making them a dominant force in the market. Ambulatory Surgical Centers are gaining traction as they offer less invasive procedures with shorter recovery times, appealing to a growing population of patients seeking efficient treatment options.

This trend is bolstered by advancements in minimally invasive surgical techniques, which enhance patient outcomes. Meanwhile, Cardiac Clinics focus on diagnosis and treatment, providing specialized care that is vital for heart valve management. These clinics are increasingly essential as they offer targeted treatments and follow-up care, addressing the specific needs of patients with heart conditions. Overall, the segmentation within the South Korea Heart Valves Market reflects a response to the evolving healthcare landscape, prioritizing efficient and specialized care to improve patient quality of life.

**Heart Valves Market Material Insights**

The South Korea Heart Valves Market focuses on the Material segment, which plays a vital role in the effectiveness and longevity of heart valve replacements. This segment is primarily composed of Biological Tissue, Synthetic Polymer, and Metallic Alloys. Biological Tissue valves are gaining popularity due to their natural compatibility with the human body, offering an appealing option for patients seeking reduced long-term complications.

On the other hand, Synthetic Polymers are increasingly significant as they provide durability and resistance to wear, catering to an active patient demographic.Metallic Alloys remain a traditional choice due to their strength and reliability, making them essential in various surgical applications. 

The diversity within the Material segment reflects ongoing innovation and investment in Research and Development, with a focus on improving patient outcomes and reducing recovery time. The South Korea Heart Valves Market data indicates that advancements in these materials are driven by the nation’s emphasis on enhancing healthcare technology and responding to a growing elderly population that demands effective cardiac solutions.This segment is vital for addressing both current needs and future trends in cardiac care within South Korea.

**South Korea Heart Valves Market Key Players and Competitive Insights**

The South Korea Heart Valves Market is characterized by a dynamic competitive landscape driven by the increasing prevalence of cardiovascular diseases and advancements in medical technology. This market features a mix of established players and emerging companies, all vying to capture market share through innovative products and strategic partnerships. The competitive insights reflect a growing trend towards minimally invasive procedures, which is shaping the development of heart valve technologies. 

Additionally, collaboration with healthcare providers and ongoing clinical trials further influence market strategies, enabling companies to enhance their offerings and improve patient outcomes. The unique regulatory environment in South Korea additionally poses both challenges and opportunities for the players in this sector, necessitating tailored approaches to product development and marketing.Neovasc has established a notable presence in the South Korean Heart Valves Market, particularly through its innovative approach to providing solutions for patients suffering from heart conditions.

The company's focus on developing advanced transcatheter technologies has positioned it as a key player in this market, where demand for less invasive treatment methods is on the rise. 

Neovasc's strengths include its commitment to research and development, which has led to the introduction of sophisticated heart valve technologies aimed at improving patient outcomes. This focus has garnered attention within the South Korean healthcare community, allowing Neovasc to build strong partnerships with local hospitals and medical professionals. The company’s agility in responding to market dynamics and emphasis on regulatory compliance further solidifies its competitive edge in South Korea.

St. Jude Medical, now part of an acquired entity, has a significant footprint in the South Korea Heart Valves Market, renowned for its diverse range of cardiac devices, including advanced heart valves and related therapies. The company's key products are designed to cater to a variety of heart valve disorders, reinforcing its position in both the surgical and interventional spaces. St. Jude Medical’s strengths lie in its robust portfolio, which addresses a broad spectrum of cardiac issues, alongside its established reputation for reliability and innovation. 

The company has actively pursued mergers and acquisitions, enhancing its market capabilities and expanding its technological prowess in heart valve solutions specific to the South Korean market. Its strategic partnerships with local healthcare providers and research institutions further facilitate access to cutting-edge innovations, ensuring that it remains a prominent player in the competitive landscape of heart valves within South Korea.

**Key Companies in the South Korea Heart Valves Market Include:**

**South Korea Heart Valves Market Industry Developments**

The South Korea Heart Valves Market is witnessing significant developments, particularly with companies such as Edwards Lifesciences, Medtronic, and Abbott Laboratories actively promoting technological advancements in heart valve therapies. In September 2023, Edwards Lifesciences launched a new transcatheter heart valve device, enhancing treatment options for patients with severe aortic stenosis. 

Additionally, Medtronic announced an expansion plan in August 2023 to increase production capacity to meet the rising demand for heart valve implants in the region. Recently, in July 2023, Sino Medical Sciences Technology secured regulatory approval for its innovative heart valve technology, indicating a robust growth trajectory in the South Korean market. 

Mergers and acquisitions remain a focal point, as in June 2023, Boston Scientific acquired a small medical device company, enhancing its heart valve product portfolio. The market has shown an upward valuation trend, attributed to an aging population and increasing incidences of cardiovascular diseases in South Korea, paving the way for more innovative solutions and strategic partnerships among key players like Neovasc and LivaNova in addressing these healthcare challenges.

**South Korea Heart Valves Market Segmentation Insights**

**Heart Valves Market Type Outlook**

**Heart Valves Market Application Outlook**

**Heart Valves Market End Use Outlook**

**Heart Valves Market Material Outlook**

- Biological Tissue
- Synthetic Polymer

## Market Drivers

### Rising Aging Population

The heart valves market in South Korea is experiencing growth due to the increasing aging population. As individuals age, the incidence of heart-related ailments tends to rise, leading to a higher demand for heart valve replacements and repairs. According to recent statistics, approximately 15% of the South Korean population is aged 65 and older, a figure projected to increase significantly in the coming years. This demographic shift is likely to drive the heart valves market, as older adults are more susceptible to conditions requiring surgical interventions. Furthermore, advancements in surgical techniques and valve technologies may enhance patient outcomes, thereby encouraging more individuals to seek treatment. The heart valves market must adapt to this demographic trend by ensuring the availability of innovative and effective solutions tailored to the needs of the elderly population.

### Increased Healthcare Expenditure

Healthcare expenditure in South Korea has been on the rise, which positively impacts the heart valves market. The government has been investing heavily in healthcare infrastructure and services, with a focus on improving cardiovascular care. In 2025, healthcare spending is expected to reach approximately 9% of the country's GDP, reflecting a commitment to enhancing medical services. This increase in funding allows for better access to advanced heart valve treatments and technologies, which may lead to improved patient outcomes. Additionally, as more healthcare facilities adopt cutting-edge technologies, the heart valves market is likely to benefit from increased demand for innovative products. The correlation between healthcare expenditure and market growth suggests that continued investment in healthcare will be crucial for the heart valves market's expansion in South Korea.

### Growing Awareness of Heart Health

There is a notable increase in public awareness regarding heart health in South Korea, which is influencing the heart valves market. Educational campaigns and health initiatives have been implemented to inform the population about the risks associated with cardiovascular diseases. As awareness grows, individuals are more likely to seek medical advice and undergo regular check-ups, leading to earlier detection of heart conditions. This proactive approach can result in a higher demand for heart valve interventions, as patients become more informed about their treatment options. The heart valves market must capitalize on this trend by providing educational resources and promoting the benefits of timely interventions. The potential for increased patient engagement and demand for heart valve solutions is significant, suggesting a positive outlook for the market.

### Technological Innovations in Medical Devices

Technological innovations are playing a pivotal role in shaping the heart valves market in South Korea. The development of minimally invasive surgical techniques and advanced materials for heart valves has revolutionized treatment options. For instance, transcatheter aortic valve replacement (TAVR) has gained popularity due to its reduced recovery time and lower risk of complications. The heart valves market is likely to see continued growth as these innovations become more widely adopted. Furthermore, research and development efforts are focused on creating biocompatible materials that enhance the longevity and performance of heart valves. As healthcare providers increasingly embrace these advancements, the demand for innovative heart valve solutions is expected to rise, indicating a dynamic future for the market.

### Rising Incidence of Lifestyle-Related Diseases

The heart valves market in South Korea is also being driven by the rising incidence of lifestyle-related diseases. Factors such as poor diet, lack of physical activity, and increased stress levels contribute to cardiovascular issues, leading to a higher demand for heart valve treatments. Recent studies indicate that nearly 30% of the South Korean population is affected by hypertension, a condition that can lead to heart valve disorders. This trend underscores the need for effective interventions and treatments within the heart valves market. As healthcare professionals address these lifestyle-related health challenges, the market is likely to expand, driven by the need for innovative solutions that cater to the growing patient population. The interplay between lifestyle factors and heart health is crucial for understanding the future trajectory of the market.

## Future Outlook

The [Heart Valves Market](https://www.marketresearchfuture.com/reports/heart-valves-market-11861) in South Korea is projected to grow at a 12.2% CAGR from 2025 to 2035, driven by technological advancements, increasing prevalence of heart diseases, and rising healthcare expenditure.

**New opportunities:**

- Development of minimally invasive valve replacement technologies
- Expansion of telehealth services for remote patient monitoring
- Investment in biodegradable heart valve materials for sustainability

By 2035, the heart valves market is expected to achieve substantial growth and innovation.

## Segment Insights

### By Application: Aortic Valve Repair (Largest) vs. Mitral Valve Repair (Fastest-Growing)

In the South Korea heart valves market, Aortic Valve Repair holds the largest market share among the application segments, driven largely by the increasing prevalence of aortic valve disorders and a robust healthcare infrastructure. Mitral Valve Repair, while smaller in market share, is experiencing rapid growth due to advancements in minimally invasive surgical techniques and rising awareness about mitral valve diseases, making it a focal point of innovation and investment.

The growth trends in these segments are reflective of broader healthcare trends, with an emphasis on improving patient outcomes and reducing recovery times. Factors such as an aging population, advancements in surgical technology, and increasing patient access to healthcare services are propelling the demand for valve repair procedures. Tricuspid Valve Repair, although growing, remains in a nascent stage compared to the other two segments, primarily due to lesser awareness and fewer clinical interventions.

Aortic Valve Repair (Dominant) vs. Mitral Valve Repair (Emerging)

Aortic Valve Repair is characterized by its widespread adoption and implementation within cardiovascular procedures, reflecting its dominant position in the market. This segment benefits from established techniques and a wealth of clinical data supporting its efficacy, making it the preferred choice for treating aortic valve issues. Conversely, Mitral Valve Repair is emerging as a significant player with its rapid growth due to novel approaches like transcatheter mitral valve repair, catering to a previously underserved patient population. With increasing investments in research and development, this segment is poised to capture a larger share of the market as awareness and medical education surrounding mitral valve disorders improve.

### By Type: Mechanical Valves (Largest) vs. Transcatheter Valves (Fastest-Growing)

The South Korea heart valves market exhibits a diverse distribution of segment values, notably led by Mechanical Valves, which have established a substantial foothold due to their durability and long-term performance. Bioprosthetic Valves also command a significant share, appealing to patients with a strong preference for tissue-based options. Transcatheter Valves, while currently smaller in market share, have proven to be an innovative solution, especially for high-risk patients who may benefit from less invasive procedures.

In terms of growth trends, Transcatheter Valves are positioned as the fastest-growing segment, driven by technological advancements and an increasing acceptance among healthcare professionals. The shift towards minimally invasive surgical techniques has fueled demand, as these valves provide patients with quicker recovery times and fewer complications. Meanwhile, Mechanical Valves continue to thrive due to their reliability, although competition from newer technologies remains a pressing factor for future growth strategies.

Mechanical Valves (Dominant) vs. Bioprosthetic Valves (Emerging)

Mechanical Valves dominate the South Korea heart valves market owing to their proven longevity and effectiveness in various patient demographics. Their robust construction often makes them the preferred choice for younger patients who may require long-term correction solutions. On the other hand, Bioprosthetic Valves are emerging as a popular alternative due to their biocompatibility and reduced need for long-term anticoagulation therapy, making them appealing for elderly patients or those with specific health considerations. As the healthcare sector continues to evolve, both segments are adapting to patient needs, with Mechanical Valves focusing on durability and Bioprosthetic options emphasizing ease of use and patient comfort.

### By End Use: Hospital (Largest) vs. Ambulatory Surgical Centers (Fastest-Growing)

In the South Korea heart valves market, the Hospital segment commands the largest share, attributed to the extensive resources and advanced technology available in these institutions. They provide comprehensive treatment options and have a high volume of patients requiring heart valve interventions. Meanwhile, the Ambulatory Surgical Centers segment, while smaller in total volume, is witnessing rapid growth due to the increasing preference for outpatient procedures and the associated cost efficiencies that these facilities offer.

Growth in the South Korea heart valves market is driven by an aging population and rising incidences of cardiovascular diseases, leading to increased demand for heart valve surgeries. Additionally, advances in minimally invasive techniques are making procedures more accessible in various settings, including Ambulatory Surgical Centers, which are poised to become critical players. Cardiac Clinics are also adapting to these trends by offering specialized care that contributes to the overall growth in the sector.

Hospital (Dominant) vs. Ambulatory Surgical Centers (Emerging)

The Hospital segment is characterized by its ability to provide complex surgical procedures and post-operative care, making it the dominant player in the market. These facilities invest heavily in advanced technologies and have multidisciplinary teams to cater to diverse patient needs, ensuring high success rates for heart valve treatments. On the other hand, Ambulatory Surgical Centers are emerging as a cost-effective alternative for less complex procedures, attracting a growing number of patients who prefer shorter recovery times and convenience. They are adapting to changing patient demographics and preferences, which bodes well for their future growth, positioning them as a crucial part of the evolving landscape of the heart valves market.

### By Material: Biological Tissue (Largest) vs. Synthetic Polymer (Fastest-Growing)

In the South Korea heart valves market, the distribution among material segments reveals that Biological Tissue is the largest segment, capturing a significant share of the market due to its preference for natural compatibility and performance. Following closely, Synthetic Polymer is emerging as a strong contender, driven by innovative applications and advancements that cater to patients' needs for durable and effective solutions. Metallic Alloys, while important, hold a smaller share as compared to these two segments, primarily utilized for specific applications.

Growth trends in the South Korea heart valves market indicate that the demand for Biological Tissue is stable but slowly shifting as more patients and healthcare providers recognize the benefits of Synthetic Polymer materials. The latter is characterized by rapid technological advancements, such as improved manufacturing processes and material properties that enhance valve function. Additionally, emerging healthcare trends focusing on patient-specific solutions are contributing to the rise of Synthetic Polymer, while Biological Tissue remains a reliable choice for traditional procedures.

Biological Tissue (Dominant) vs. Synthetic Polymer (Emerging)

Biological Tissue has solidified its position as the dominant segment in the South Korea heart valves market, owing to its natural compatibility and efficacy in mimicking the physiological functions of human tissues. It is extensively used in surgical procedures, offering patients reduced risk of complications and improved health outcomes. On the other hand, Synthetic Polymer represents an emerging segment, characterized by continuous innovation that enhances its performance and patient acceptability. The rise of customized solutions tailored to individual needs is pushing the demand for Synthetic Polymer, which is rapidly gaining favor due to its adaptability, lower manufacturing costs, and significant advancements in biocompatibility, making it a competitive alternative to traditional materials.

### Heart Valves Market Material Insights

Heart Valves Market Material Insights

The South Korea Heart Valves Market focuses on the Material segment, which plays a vital role in the effectiveness and longevity of heart valve replacements. This segment is primarily composed of Biological Tissue, Synthetic Polymer, and Metallic Alloys. Biological Tissue valves are gaining popularity due to their natural compatibility with the human body, offering an appealing option for patients seeking reduced long-term complications.

On the other hand, Synthetic Polymers are increasingly significant as they provide durability and resistance to wear, catering to an active patient demographic.Metallic Alloys remain a traditional choice due to their strength and reliability, making them essential in various surgical applications. 

The diversity within the Material segment reflects ongoing innovation and investment in Research and Development, with a focus on improving patient outcomes and reducing recovery time. The South Korea Heart Valves Market data indicates that advancements in these materials are driven by the nation’s emphasis on enhancing healthcare technology and responding to a growing elderly population that demands effective cardiac solutions.This segment is vital for addressing both current needs and future trends in cardiac care within South Korea.

## Competitive Benchmarking

The heart valves market in South Korea is characterized by a competitive landscape that is increasingly shaped by innovation, strategic partnerships, and regional expansion. Key players such as Edwards Lifesciences (US), Medtronic (US), and Abbott Laboratories (US) are at the forefront, leveraging their technological advancements and extensive product portfolios to capture market share. Edwards Lifesciences (US) focuses on transcatheter heart valve technologies, which are gaining traction due to their minimally invasive nature. Medtronic (US) emphasizes a broad range of heart valve solutions, including surgical and transcatheter options, while Abbott Laboratories (US) is known for its innovative approaches in valve repair and replacement technologies. Collectively, these strategies foster a dynamic competitive environment, driving growth and enhancing patient outcomes.
In terms of business tactics, companies are increasingly localizing manufacturing and optimizing supply chains to enhance efficiency and reduce costs. The market structure appears moderately fragmented, with several players vying for dominance. However, the influence of major companies is substantial, as they set industry standards and drive technological advancements. This competitive structure allows for a diverse range of products and solutions, catering to varying patient needs and preferences.
In October 2025, Edwards Lifesciences (US) announced the launch of its latest transcatheter aortic valve replacement (TAVR) system, which incorporates advanced imaging technology to improve procedural outcomes. This strategic move is likely to enhance the company's market position by addressing the growing demand for less invasive surgical options, thereby appealing to both healthcare providers and patients seeking improved recovery times.
In September 2025, Medtronic (US) expanded its partnership with a leading South Korean hospital network to enhance clinical research and development of heart valve technologies. This collaboration is expected to facilitate the introduction of innovative products tailored to the specific needs of the South Korean market, thereby strengthening Medtronic's foothold in the region and fostering long-term growth.
In August 2025, Abbott Laboratories (US) secured regulatory approval for its new heart valve repair device, which utilizes a unique delivery system designed to minimize complications during procedures. This approval not only underscores Abbott's commitment to innovation but also positions the company to capitalize on the increasing demand for effective and safe heart valve solutions in South Korea.
As of November 2025, current trends in the heart valves market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence (AI) in product development and patient management. Strategic alliances among key players are shaping the competitive landscape, enabling companies to pool resources and expertise. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition to a focus on innovation, technological advancements, and supply chain reliability, as companies strive to meet the growing expectations of healthcare providers and patients alike.

## Recent News & Developments

The South Korea Heart Valves Market is witnessing significant developments, particularly with companies such as Edwards Lifesciences, Medtronic, and Abbott Laboratories actively promoting technological advancements in heart valve therapies. In September 2023, Edwards Lifesciences launched a new transcatheter heart valve device, enhancing treatment options for patients with severe aortic stenosis. 

Additionally, Medtronic announced an expansion plan in August 2023 to increase production capacity to meet the rising demand for heart valve implants in the region. Recently, in July 2023, Sino Medical Sciences Technology secured regulatory approval for its innovative heart valve technology, indicating a robust growth trajectory in the South Korean market. 

Mergers and acquisitions remain a focal point, as in June 2023, Boston Scientific acquired a small medical device company, enhancing its heart valve product portfolio. The market has shown an upward valuation trend, attributed to an aging population and increasing incidences of cardiovascular diseases in South Korea, paving the way for more innovative solutions and strategic partnerships among key players like Neovasc and LivaNova in addressing these healthcare challenges.

## Report Scope

| MARKET SIZE 2024 | 227.2(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 254.92(USD Million) |
| MARKET SIZE 2035 | 806.17(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 12.2% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Edwards Lifesciences (US), Medtronic (US), Boston Scientific (US), Abbott Laboratories (US), LivaNova (GB), JenaValve Technology (DE), Sorin Group (IT), CryoLife (US) |
| Segments Covered | Application, Type, End Use, Material |
| Key Market Opportunities | Advancements in minimally invasive procedures enhance growth potential in the heart valves market. |
| Key Market Dynamics | Technological advancements and regulatory changes drive innovation in the heart valves market, enhancing patient outcomes in South Korea. |
| Countries Covered | South Korea |

## Frequently Asked Questions

**Q: What is the current valuation of the heart valves market in South Korea?**
A: The heart valves market in South Korea was valued at $227.2 Million in 2024.

**Q: What is the projected market valuation for the heart valves market in South Korea by 2035?**
A: The market is projected to reach $806.17 Million by 2035.

**Q: What is the expected CAGR for the heart valves market in South Korea during the forecast period 2025 - 2035?**
A: The expected CAGR for the heart valves market during the forecast period 2025 - 2035 is 12.2%.

**Q: Which companies are the key players in the South Korea heart valves market?**
A: Key players in the market include Edwards Lifesciences, Medtronic, Boston Scientific, Abbott Laboratories, LivaNova, JenaValve Technology, Sorin Group, and CryoLife.

**Q: What are the main application segments in the South Korea heart valves market?**
A: The main application segments include Aortic Valve Repair, Mitral Valve Repair, and Tricuspid Valve Repair.

**Q: How did the Aortic Valve Repair segment perform in 2024?**
A: The Aortic Valve Repair segment was valued at $45.0 Million in 2024 and is expected to grow significantly.

**Q: What is the valuation of the Mitral Valve Repair segment in 2024?**
A: The Mitral Valve Repair segment was valued at $90.0 Million in 2024.

**Q: What types of heart valves are included in the South Korea market?**
A: The types of heart valves include Mechanical Valves, Bioprosthetic Valves, and Transcatheter Valves.

**Q: What was the market valuation for Bioprosthetic Valves in 2024?**
A: The Bioprosthetic Valves segment was valued at $90.88 Million in 2024.

**Q: Which end-use segments are present in the South Korea heart valves market?**
A: End-use segments include Hospitals, Ambulatory Surgical Centers, and Cardiac Clinics.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/south-korea-heart-valves-market-52107*